Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Skip to content
ALS News Today logo
  • HCP Portal
  • Home
  • About ALS
    What Is ALS?
    Symptoms
    Causes
    • Genetics
    Diagnosis
    Living With ALS
    Forms of ALS
    • Familial ALS
    • Sporadic ALS
  • Treatments
    Approved Treatments
    Experimental Treatments
    Non-drug Treatments
  • News
  • Columns
    Joyful Sorrow — Kristin Neva
    Living Well With ALS — Dagmar Munn
    Notes From the ALS Front — Rick Jobus
    Archived Columns
    • The Mighty Mind — Rachel Doboga
  • Forums
  • What can we help you find today?

    • HCP Portal
  • Social Clips
  • Last Week’s Top-3 Most Read Posts On ALS

Last Week’s Top-3 Most Read Posts On ALS

admin avatar

by admin | January 18, 2016

Share this article:

Share article via email

Read the Articles Here:

ALS Stem Cell Therapy Seen to Benefit Patients in First Round of Clinical Tests

ALS Patients Show Increased Response to Specific Receptor in Spinal Cord

ALS Severity, Duration May Be Linked to Glutamate Toxicity

 

Print This Page

Tags

glutamate, most read, receptor in spinal cord, stem cell therapy, top 3

Recent Posts

  • FDA Panel Reconvenes in September to Discuss AMX0035 Approval
  • My ALS Week: Voice Therapy, New Exercise Ideas, and the Loss of a Colleague
  • Radicava’s Real-world Safety Profile Matches Clinical Trial Data: Study
  • From a Devastating Diagnosis to “Embracing My Now” with ALS
  • FDA Shares Plan for ALS, Other Neurodegenerative Diseases
  • PrimeC Therapy Added to Standard Care Gets ALS Biomarkers Down
  • We Are Always Preparing to Manage Life on Our Own
  • Finding TDP-43 Clumps in Muscle Biopsies May Speed Diagnosis
  • In Memoriam: Rick Jobus, Feb. 6, 1958-June 19, 2022
  • I Just Received a Diagnosis of ALS. What Now?

Recommended reading

voice therapy | ALS News Today | Banner for
July 5, 2022 Columns by Dagmar Munn

My ALS Week: Voice Therapy, New Exercise Ideas, and the Loss of a Colleague

ALS Radicava | ALS News Today | Target ALS Biomarker study enrolling | illustration of doctor talking to patient
July 5, 2022 News by Marisa Wexler, MS

Radicava’s Real-world Safety Profile Matches Clinical Trial Data: Study

July 1, 2022 Sponsored Articles by Juan Reyes

From a Devastating Diagnosis to “Embracing My Now” with ALS

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

BioNews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Corrections Policy
  • Advertising Policy
  • Privacy Policy
  • Careers
  • Contact Us
  • Terms of Service
  • Disable Notifications
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2022 All rights reserved.

Pin It on Pinterest